Osteoporosis International

, Volume 22, Issue 12, pp 2973–2980 | Cite as

Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system

  • A. Shibli-Rahhal
  • M. S. Vaughan-Sarrazin
  • K. Richardson
  • P. Cram
Original Article



Older veterans with acute hip fracture do not receive adequate evaluation and treatment for osteoporosis, irrespective of their age and underlying health status.


Hip fractures are a serious complication of osteoporosis, leading to high mortality and morbidity. Prior studies have found significant undertreatment of osteoporosis in women with hip fracture. We examined the rate of bone density (BMD) testing and osteoporosis treatment among a predominantly male population hospitalized with hip fractures.


We conducted a retrospective cohort study of patients age 65 years and older hospitalized in U.S. Department of Veterans Affairs (VA) hospitals with hip fracture (N = 3,347) between 1 October, 2004 and 30 September, 2006. The primary outcome was receipt of BMD testing or initiation of pharmacotherapy within 12 months of fracture.


The mean age of the study population was 79.0 years (SD = 6.7), 96.5% were male, and 83.3% were white. Only 1.2% of hip fracture patients underwent BMD testing and 14.5% received osteoporosis therapy within 12 months of fracture. Among fracture patients with minimal comorbid illness (N = 756) only 1.6% underwent BMD testing and 13.0% received pharmacotherapy. In logistic regression models, treatment rates were higher for women compared to men (odds ratio, 3.30; 95% CI, 2.16–5.04) and lower for blacks compared to whites (odds ratio, 0.67; 95% CI, 0.45–0.99).


Evaluation and treatment of osteoporosis among patients with fractures is suboptimal even in an integrated healthcare delivery system with generous pharmaceutical coverage. This study suggests that the undertreatment of osteoporosis demonstrated in the private sector is also present within the VA.


Fracture Hip Osteoporosis Veterans 


  1. 1.
    Bergström U, Bjornstig U, Stenlund H, Jonsson H, Svensson O (2008) Fracture mechanisms and fracture pattern in men and women aged 50 years and older: a study of a 12-years population-based register, Umea, Sweden. Osteoporos Int 19:1267–1273PubMedCrossRefGoogle Scholar
  2. 2.
    Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650PubMedCrossRefGoogle Scholar
  3. 3.
    Beringer TR, Clarke J, Elliott JR, Marsh DR, Heyburn G, Steele IC (2006) Outcome following proximal femoral fracture in Northern Ireland. Ulster Med J 75:200–206PubMedGoogle Scholar
  4. 4.
    Koval KJ, Zuckerman JD (1994) Functional recovery after fracture of the hip. J Bone Joint Surg Am 76:751–758PubMedGoogle Scholar
  5. 5.
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRefGoogle Scholar
  6. 6.
    van Staa TP, Leufkens HG, Cooper C (2002) Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 13:624–629PubMedCrossRefGoogle Scholar
  7. 7.
    Colón-Emeric CS, Sloane R, Hawkes WG (2000) The risk of subsequent fractures in community dwelling men and male veterans with hip fracture. Am J Med 109:324–326PubMedCrossRefGoogle Scholar
  8. 8.
    National Osteoporosis Foundation (2010) Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DCGoogle Scholar
  9. 9.
    Juby AG, De Geus-Wenceslau CM (2002) Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 13:205–210PubMedCrossRefGoogle Scholar
  10. 10.
    Follin SL, Black JN, McDermott MT (2003) Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 23:190–198PubMedCrossRefGoogle Scholar
  11. 11.
    Torgerson DJ, Dolan P (1998) Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 57:378–379PubMedCrossRefGoogle Scholar
  12. 12.
    Kamel HK, Hussain MS, Tariq ST, Perry HM III, Morley JE (2000) Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109:326–328PubMedCrossRefGoogle Scholar
  13. 13.
    Andrade SE, Majumdar SR, Chan A, Buist DSM, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052–2057PubMedCrossRefGoogle Scholar
  14. 14.
    Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, Hochberg MC, McClung MR, Schnitzer TJ (2003) Pins and plasters aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88:3482–3486PubMedCrossRefGoogle Scholar
  15. 15.
    Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRefGoogle Scholar
  16. 16.
    Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA (2002) Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 47:651–654PubMedCrossRefGoogle Scholar
  17. 17.
    Kamel HK, Bida A (2004) Secondary prevention of hip fractures in veterans: can we do better? J Am Geriatr Soc 52:647–648PubMedCrossRefGoogle Scholar
  18. 18.
    Riley RL, Cames ML, Gudmundsson A, Elliott ME (2002) Outcomes and secondary prevention strategies for male hip fractures. Ann Pharmacother 36:17–23PubMedCrossRefGoogle Scholar
  19. 19.
    Colo'n-Emeric C, Yballe L, Sloane R, Pieper CF, Lyles KW (2000) Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic hip fracture. J Am Geriatr Soc 48:1261–1263Google Scholar
  20. 20.
    Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139PubMedCrossRefGoogle Scholar
  21. 21.
    Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27PubMedCrossRefGoogle Scholar
  22. 22.
    Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 85-A:1837–1843PubMedGoogle Scholar
  23. 23.
    Levinson MR, Clay FJ (2009) Barriers to the implementation of evidence in osteoporosis treatment in hip fracture. Int Med J 39:199–202CrossRefGoogle Scholar
  24. 24.
    Sheehan J, Mohamed F, Reilly M, Perry IJ (2000) Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Ir Med J 93:105–107PubMedGoogle Scholar
  25. 25.
    Simonelli C, Killeen K, Mehle S, Swanson L (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77:334–338PubMedCrossRefGoogle Scholar
  26. 26.
    Roerholt C, Eiken P, Abrahamsen B (2009) Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 20:299–307PubMedCrossRefGoogle Scholar
  27. 27.
    Kiezbak GM, Beinart GA, Perser K, Ambrose CG, Sift SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217–2222CrossRefGoogle Scholar
  28. 28.
    Panneman MJ, Lips P, Sen SS, Herings RM (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15:120–124PubMedCrossRefGoogle Scholar
  29. 29.
    Al Attia H, Adams B (2007) Osteoporosis in men: are we referring enough for DXA and how? Clin Rheumatol 26:1123–1126PubMedCrossRefGoogle Scholar
  30. 30.
    Madeo B, Zirilli L, Caffagni G, Diazzi C, Sanguanini A, Pignatti E, Carani C, Rochira V (2007) The osteoporotic male: overlooked and undermanaged? Clin Interv Aging 2:305–312PubMedGoogle Scholar
  31. 31.
    Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fracture. Osteoporos Int 17:1726–1733PubMedCrossRefGoogle Scholar
  32. 32.
    Ringe JD, Farahmand P, Faber H, Dorst A (2009) Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol Int 29:311–315PubMedCrossRefGoogle Scholar
  33. 33.
    Kaufman JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH (2005) Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int 16:510–516PubMedCrossRefGoogle Scholar
  34. 34.
    Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, Recurrent Fracture Trial HORIZON (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809PubMedCrossRefGoogle Scholar
  35. 35.
    Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610PubMedCrossRefGoogle Scholar
  36. 36.
    McQueen L, Mittman BS, Demakis JG (2004) Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI). J Am Med Inform Assoc 11:339–343PubMedCrossRefGoogle Scholar
  37. 37.
    Department of Veterans Affairs Office of Inspector General (2010) Healthcare Inspection Management of osteoporosis in veterans with fractures; Rpt # 09-03138-191. http://www4.va.gov/oig/54/reports/VAOIG-09-03138-191.pdf. Accessed 12 November 2010.
  38. 38.
    Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, Aickin M, Swain MC (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54:450–457PubMedCrossRefGoogle Scholar
  39. 39.
    Mjumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, Morrish DW, Maksymowych WP, Rowe BH (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178:569–575CrossRefGoogle Scholar
  40. 40.
    Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, Maksymowych WP, Cinats JG, Bell NR, Morrish DW (2007) Use of a case manager to improve osteoporosis treatment after hip fracture. Results of a randomized controlled trial. Arch Intern Med 167:2110–2115PubMedCrossRefGoogle Scholar
  41. 41.
    Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179PubMedCrossRefGoogle Scholar
  42. 42.
    Jones G, Warr S, Francis E, Greenaway T (2005) The effect of a fracture protocol on hospital prescriptions after minimal trauma fractured neck of the femur: a retrospective audit. Osteoporos Int 16:1277–1280PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2011

Authors and Affiliations

  • A. Shibli-Rahhal
    • 1
  • M. S. Vaughan-Sarrazin
    • 2
    • 3
  • K. Richardson
    • 2
  • P. Cram
    • 2
    • 3
  1. 1.Division of Endocrinology, Diabetes and Metabolism, Department of Internal MedicineUniversity of Iowa Carver College of MedicineIowa CityUSA
  2. 2.Center for Comprehensive Access and Delivery Research and Evaluation (CADRE), Iowa City Veterans Administration Medical CenterIowa CityUSA
  3. 3.Division of General Internal Medicine, Department of Internal MedicineUniversity of Iowa Carver College of MedicineIowa CityUSA

Personalised recommendations